bearish

Mankind Pharma

Mankind Pharma Pre-IPO - The Negatives - Recent Updates Weren't Great

Mankind Pharma is looking to raise about US$1bn in its upcoming India IPO. In this note, we talk about the not-so-positive aspects of the deal.

Equity Capital Markets
388 Views, 26 Jan 2023 11:46
SUMMARY(Sign Up to Access)
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
  • Unlimited Research Summaries
  • Personalised Alerts
  • Custom Watchlists
  • Company Data & News
  • Events & Webinars
or
Trusted by:
Bloomberg
Societe Generale
SGX
Sequoia
Interactive Broker
Refinitiv
Already have an account? Sign In Now
Full Insight
(Paid Plans Only)
Discussions
(Paid Plans Only)
WHAT’S TRENDING
Insights
  • Trending
  • Latest
Logo
Top 5%
Sumeet Singh
Head of Research, IPOs & Placements
Aequitas Research
EquitiesEquity Capital Markets
Price Chart(Sign Up to Access)
analytics-chart
  • ECM Weekly (12th Feb 2023) - Hesai, Oasis, Mankind, Greatpower, Ruipeng, CATL, Nissan/Renault
    12 Feb 2023
  • Mankind Pharma Pre-IPO - Thoughts on Valuations
    09 Feb 2023
  • Mankind Pharma Pre-IPO - Peer Comparison - One of the Largest, with Better Growth and Margins
    08 Feb 2023
  • Mankind Pharma Pre-IPO - The Negatives - Recent Updates Weren't Great
    26 Jan 2023
  • Mankind Pharma Pre-IPO - The Positives - Diverse Portfolio with Steady past Performance
    25 Jan 2023
  • Mankind Pharma Pre-IPO Tearsheet
    20 Sep 2022
x